Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)